Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer
Clinical trial NCT03165591 · UNKNOWN
Trial details
- NCT number
- NCT03165591
- Sponsor
- Immunitor LLC
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2020-02-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.